The director of the Institute of Translational Medicine and Biotechnology at Moscow State Medical University said that they have developed artificial intelligence at the Pharmacy Artificial Intelligence Center of Sechenov University, which can reduce the production time of drugs to one year in the future. socialbites.ca about this. Sechenov, professor Vadim Tarasov.
We are talking about generics, these are copies of drugs. Once the patent holder’s patent on an original drug expires, other companies can begin producing it. But first, technologists need to recreate the “recipe” of the drug described in the patent, without technical nuances.
“If we are talking about artificial intelligence, it significantly speeds up the process of collecting information, eliminates everything unnecessary, minimizes the number of errors and provides the most rational technological options: how to make technology, Tarasov explained what raw materials, in what formats and with what to work.
Now this process takes about 12-15 months, artificial intelligence will help reduce this time by 30-40% to 10 months without obtaining a registration certificate.
“There are definitely some steps that will be reduced: data collection and analysis. There are also things to do with the accumulation of sample numbers. Here we cannot say whether the neural network will help reduce their number, by how much, and how these changes will affect the overall timing of drug release. If you are dreaming, the ideal would be to shorten the generic creation process by up to a year by obtaining the registration dossier,” concluded Tarasov.
Read more about scientists’ work material “socialbites.ca”.
Previous scientists was created The most accurate neural network to detect COVID-19 in the lungs.